ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07011706 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07011706
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-30
- Primary completion
- 2026-08-01
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.